Immunity to pertussis 5 years after booster immunization during adolescence

被引:71
作者
Edelman, Kati
He, Qiushui
Makinen, Johanna
Sahlberg, Anna
Haanpera, Marjo
Schuerman, Lode
Wolter, Joanne
Mertsola, Jussi
机构
[1] Turku Univ Hosp, Dept Pediat, Turku 20520, Finland
[2] Natl Publ Hlth Inst, Dept Bacterial & Inflammatory Dis, Turku, Finland
[3] GlaxoSmithKline Biol, Rixensart, Belgium
关键词
D O I
10.1086/514338
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. We conducted a 5-year follow-up study on the persistence of pertussis-specific antibody and cell-mediated immunity after booster immunization of adolescents aged 11-13 years with a tricomponent acellular pertussis vaccine (Boostrix; trials diphtheria-tetanus - acellular pertussis [Tdap] - 004/030). Methods. Cellular and humoral immunity to pertussis toxin (PT), filamentous hemagglutinin, and pertactin were measured in adolescents (age, 16 years) 5 years after booster immunization. Similar investigations were performed for control adolescents who had received only diphtheria and tetanus booster vaccination. Results. Five years after pertussis booster vaccination, the geometric mean concentrations of immunoglobulin G (IgG) elicited by each of the 3 pertussis vaccine antigens decreased from 1-month and 3-year postvaccination levels, but with the exception of PT IgG, were still higher than the prevaccination levels. PT IgG levels were undetectable in 28% of the subjects, but 44% of those subjects still tested positive for cell-mediated immunity to PT. Filamentous hemagglutinin IgG and pertactin IgG levels were significantly higher in Tdap-boosted adolescents than in the control subjects. Antibody concentrations at 1 month after vaccination strongly predicted antibody persistence. Cell-mediated immunity levels to PT, filamentous hemagglutinin, and pertactin persisted above the prebooster levels measured 5 years earlier. Conclusions. The results of the present study of adolescents indicate that the interval between acellular pertussis booster immunizations might be extended beyond 5 years.
引用
收藏
页码:1271 / 1277
页数:7
相关论文
共 40 条
[1]   Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines [J].
Cassone, A ;
Ausiello, CM ;
Urbani, F ;
Lande, R ;
Giuliano, M ;
LaSala, A ;
Piscitelli, A ;
Salmaso, S .
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 1997, 151 (03) :283-289
[2]   Resurgence of pertussis in Europe [J].
Celentano, LP ;
Massari, M ;
Paramatti, D ;
Salmaso, S ;
Tozzi, AE .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2005, 24 (09) :761-765
[3]   Epidemiology of pertussis [J].
Cherry, JD .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2006, 25 (04) :361-362
[4]   HOUSEHOLD CONTACT STUDY OF BORDETELLA-PERTUSSIS INFECTIONS [J].
DEEN, JL ;
MINK, CM ;
CHERRY, JD ;
CHRISTENSON, PD ;
PINEDA, EF ;
LEWIS, K ;
BLUMBERG, DA ;
ROSS, LA .
CLINICAL INFECTIOUS DISEASES, 1995, 21 (05) :1211-1219
[5]   Pertussis-specific cell-mediated and humoral immunity in adolescents 3 years after booster immunization with acellular pertussis vaccine [J].
Edelman, KJ ;
He, QS ;
Makinen, JP ;
Haanpera, MS ;
Minh, NNT ;
Schuerman, L ;
Wolter, J ;
Mertsola, JA .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (02) :179-185
[6]   National study of infants hospitalized with pertussis in the acellular vaccine era [J].
Elliott, E ;
McIntyre, P ;
Ridley, G ;
Morris, A ;
Massie, J ;
McEniery, J ;
Knight, G .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (03) :246-252
[7]   Long-term pertussis-specific immunity after primary vaccination with a combined diphtheria, tetanus, tricomponent acellular pertussis, and hepatitis B vaccine in comparison with that after natural infection [J].
Esposito, S ;
Agliardi, T ;
Giammanco, A ;
Faldella, G ;
Cascio, A ;
Bosis, S ;
Friscia, O ;
Clerici, M ;
Principi, N .
INFECTION AND IMMUNITY, 2001, 69 (07) :4516-4520
[8]   EPIDEMIOLOGIC FEATURES OF PERTUSSIS IN THE UNITED-STATES, 1980-1989 [J].
FARIZO, KM ;
COCHI, SL ;
ZELL, ER ;
BRINK, EW ;
WASSILAK, SG ;
PATRIARCA, PA .
CLINICAL INFECTIOUS DISEASES, 1992, 14 (03) :708-719
[9]   New pertussis vaccination strategies beyond infancy:: Recommendations by the global pertussis initiative [J].
Forsyth, KD ;
Campins-Marti, M ;
Caro, J ;
Cherry, JD ;
Greenberg, D ;
Guiso, N ;
Heininger, U ;
Schellekens, J ;
Tan, T ;
von König, CHW ;
Plotkin, S .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (12) :1802-1809
[10]   Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis [J].
Giuliano, M ;
Mastrantonio, P ;
Giammanco, A ;
Piscitelli, A ;
Salmaso, S ;
Wassilak, SGF .
JOURNAL OF PEDIATRICS, 1998, 132 (06) :983-988